Exendin-4 improves resistance to Listeria monocytogenes infection in diabetic db/db mice

Journal of Veterinary Science

Volumn 13, Issue 3, 2012, Pages 245-252

  Liu, Hsien Yueh ^a   Chung, Chih Yao ^a   Yang, Wen Chin ^b   Liang, Chih Lung ^c   Wang, Chi Young ^a   Chang, Chih Yu ^a   Chang, Cicero Lee Tian ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Diabetes mellitus; Exendin 4; Listeria monocytogenes; Macrophage; Mice

Indexed keywords

ABC TRANSPORTER; ABC TRANSPORTER A1; ANTIDIABETIC AGENT; CHOLESTEROL; EXENDIN 4; PEPTIDE; VENOM;

AGE; ANIMAL; ARTICLE; BLOOD ANALYSIS; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; GENETICS; HYPERGLYCEMIA; IMMUNOLOGY; INTRAPERITONEAL DRUG ADMINISTRATION; LIPID METABOLISM; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGE; METABOLISM; MICROBIOLOGY; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PHAGOCYTOSIS;

AGE FACTORS; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BLOOD CHEMICAL ANALYSIS; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HYPERGLYCEMIA; HYPOGLYCEMIC AGENTS; INJECTIONS, INTRAPERITONEAL; LIPID METABOLISM; LISTERIA MONOCYTOGENES; LISTERIOSIS; MACROPHAGES; MICE; OBESITY; PEPTIDES; PHAGOCYTOSIS; VENOMS;

EID: 84867438838     PISSN: 1229845X     EISSN: 1976555X     Source Type: Journal    
DOI: 10.4142/jvs.2012.13.3.245     Document Type: Article

References (40)

1. Bailey CJ. New therapies for diabesity. Curr Diab Rep 2009, 9, 360-367.
2. Barber TM, Begbie H, Levy J. The incretin pathway as a new therapeutic target for obesity. Maturitas 2010, 67, 197-202.
3. Bared SM, Buechler C, Boettcher A, Dayoub R, Sigruener A, Grandl M, Rudolph C, Dada A, Schmitz G. Association of ABCA1 with syntaxin 13 and flotillin-1 and enhanced phagocytosis in tangier cells. Mol Biol Cell 2004, 15, 5399-5407.
4. Bennett N. Monitoring techniques for diabetes mellitus in the dog and the cat. Clin Tech Small Anim Pract 2002, 17, 65-69.
5. Berfield AK, Abrass CK. IGF-1 induces foam cell formation in rat glomerular mesangial cells. J Histochem Cytochem 2002, 50, 395-403.
6. Calder PC, Bond JA, Harvey DJ, Gordon S, Newsholme EA. Uptake and incorporation of saturated and unsaturated fatty acids into macrophage lipids and their effect upon macrophage adhesion and phagocytosis. Biochem J 1990, 269, 807-814.
7. Chen D, Liao J, Li N, Zhou C, Liu Q, Wang G, Zhang R, Zhang S, Lin L, Chen K, Xie X, Nan F, Young AA, Wang MW. A nonpeptidic agonist of glucagon-like peptide 1 receptors with efficacy in diabetic db/db mice. Proc Natl Acad Sci USA 2007, 104, 943-948.
8. Clements RS Jr, Bell DSH. Complications of diabetes. Prevalence, detection, current treatment, and prognosis. Am J Med 1985, 79 (Suppl 5A), 2-7.
9. Crenshaw KL, Peterson ME. Pretreatment clinical and laboratory evaluation of cats with diabetes mellitus: 104 cases (1992-1994). J Am Vet Med Assoc 1996, 209, 943-949.
10. DeFronzo RA, Ratner RE, Han J, Kim DD, Fineman MS, Baron AD. Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes. Diabetes Care 2005, 28, 1092-1100.
11. Gilor C, Graves TK, Gilor S, Ridge TK, Rick M. The GLP-1 mimetic exenatide potentiates insulin secretion in healthy cats. Domest Anim Endocrinol 2011, 41, 42-49.
12. Glass EJ, Stewart J, Weir DM. Altered immune function in alloxan-induced diabetes in mice. Clin Exp Immunol 1986, 65, 614-621.
13. Guest CB, Hartman ME, O'Connor JC, Chakour KS, Sovari AA, Freund GG. Phagocytosis of cholesteryl ester is amplified in diabetic mouse macrophages and is largely mediated by CD36 and SR-A. PLoS One 2007, 2, e511.
14. Haghpassand M, Bourassa PAK, Francone OL, Aiello RJ. Monocyte/macrophage expression of ABCA1 has minimal contribution to plasma HDL levels. J Clin Invest 2001, 108, 1315-1320.
15. Hoenig M. Comparative aspects of diabetes mellitus in dogs and cats. Mol Cell Endocrinol 2002, 197, 221-229.
16. Hoenig M, Dawe DL. A qualitative assay for beta cell antibodies. Preliminary results in dogs with diabetes mellitus. Vet Immunol Immunopathol 1992, 32, 195-203.
17. Hoenig M, Jordan ET, Ferguson DC, de Vries F. Oral glucose leads to a differential response in glucose, insulin, and GLP-1 in lean versus obese cats. Domest Anim Endocrinol 2010, 38, 95-102.
18. Ikejima S, Sasaki S, Sashinami H, Mori F, Ogawa Y, Nakamura T, Abe Y, Wakabayashi K, Suda T, Nakane A. Impairment of host resistance to Listeria monocytogenes infection in liver of db/db and ob/ob mice. Diabetes 2005, 54, 182-189.
19. Ionut V, Liberty IF, Hucking K, Lottati M, Stefanovski D, Zheng D, Bergman RN. Exogenously imposed postprandiallike rises in systemic glucose and GLP-1 do not produce an incretin effect, suggesting an indirect mechanism of GLP-1 action. Am J Physiol Endocrinol Metab 2006, 291, E779-E785.
20. Joshi N, Caputo GM, Weitekamp MR, Karchmer AW. Infections in patients with diabetes mellitus. N Engl J Med 1999, 341, 1906-1912.
21. Kaiyala KJ, Prigeon RL, Kahn SE, Woods SC, Porte D Jr, Schwartz MW. Reduced β-cell function contributes to impaired glucose tolerance in dogs made obese by high-fat feeding. Am J Physiol Endocrinol Metab 1999, 277, E659-E667.
22. Kobayashi K, Forte TM, Taniguchi S, Ishida BY, Oka K, Chan L. The db/db mouse, a model for diabetic dyslipidemia: molecular characterization and effects of Western diet feeding. Metabolism 2000, 49, 22-31.
23. Lecube A, Pachón G, Petriz J, Hernández C, Simó R. Phagocytic activity is impaired in type 2 diabetes mellitus and increases after metabolic improvement. PLoS One 2011, 6, e23366.
24. Lutz TA, Rand JS. Pathogenesis of feline diabetes mellitus. Vet Clin North Am Small Anim Pract 1995, 25, 527-552.
25. Mayr A. Infections which humans in the household transmit to dogs and cats. Zentralbl Bakteriol Mikrobiol Hyg B 1989, 187, 508-526.
26. Melo RCN, Fabrino DL, Dias FF, Parreira GG. Lipid bodies: structural markers of inflammatory macrophages in innate immunity. Inflamm Res 2006, 55, 342-348.
27. Mittelman SD, Van Citters GW, Kirkman EL, Bergman RN. Extreme insulin resistance of the central adipose depot in vivo. Diabetes 2002, 51, 755-761.
28. Panciera DL, Thomas CB, Eicker SW, Atkins CE. Epizootiologic patterns of diabetes mellitus in cats: 333 cases (1980-1986). J Am Vet Med Assoc 1990, 197, 1504-1508.
29. Portnoy DA, Jacks PS, Hinrichs DJ. Role of hemolysin for the intracellular growth of Listeria monocytogenes. J Exp Med 1988, 167, 1459-1471.
30. Pridal L, Deacon CF, Kirk O, Christensen JV, Carr RD, Holst JJ. Glucagon-like peptide-1(7-37) has a larger volume of distribution than glucagon-like peptide-1(7-36)amide in dogs and is degraded more quickly in vitro by dog plasma. Eur J Drug Metab Pharmacokinet 1996, 21, 51-59.
31. Rand JS, Fleeman LM, Farrow HA, Appleton DJ, Lederer R. Canine and feline diabetes mellitus: nature or nurture? J Nutr 2004, 134 (Suppl), 2072S-2080S.
32. Repp H, Pamukçi Z, Koschinski A, Domann E, Darji A, Birringer J, Brockmeier D, Chakraborty T, Dreyer F. Listeriolysin of Listeria monocytogenes forms Ca2+-permeable pores leading to intracellular Ca2+ oscillations. Cell Microbiol 2002, 4, 483-491.
33. Rotella CM, Pala L, Mannucci E. Glucagon-like peptide 1 (GLP-1) and metabolic diseases. J Endocrinol Invest 2005, 28, 746-758.
34. Schlech WF 3rd, Lavigne PM, Bortolussi RA, Allen AC, Haldane EV, Wort AJ, Hightower AW, Johnson SE, King SH, Nicholls ES, Broome CV. Epidemic listeriosis--evidence for transmission by food. N Engl J Med 1983, 308, 203-206.
35. Schoder D, Melzner D, Schmalwieser A, Zangana A, Winter P, Wagner M. Important vectors for Listeria monocytogenes transmission at farm dairies manufacturing fresh sheep and goat cheese from raw milk. J Food Prot 2011, 74, 919-924.
36. Skogberg K, Syrjänen J, Jahkola M, Renkonen OV, Paavonen J, Ahonen J, Kontiainen S, Ruutu P, Valtonen V. Clinical presentation and outcome of listeriosis in patients with and without immunosuppressive therapy. Clin Infect Dis 1992, 14, 815-821.
37. Slavov E, Georgiev IP, Dzhelebov P, Kanelov I, Andonova M, Georgieva TM, Dimitrova S. High-fat feeding and Staphylococcus intermedius infection impair beta cell function and insulin sensitivity in mongrel dogs. Vet Res Commun 2010, 34, 205-215.
38. Smyth S, Heron A. Diabetes and obesity: the twin epidemics. Nat Med 2006, 12, 75-80.
39. Truett AA, Borne AT, Monteiro MP, West DB. Composition of dietary fat affects blood pressure and insulin responses to dietary obesity in the dog. Obes Res 1998, 6, 137-146.
40. Young AA, Gedulin BR, Bhavsar S, Bodkin N, Jodka C, Hansen B, Denaro M. Glucose-lowering and insulinsensitizing actions of exendin-4. Studies in obese diabetic (ob/ob, db/db) mice, diabetic fatty Zucker rats, and diabetic rhesus monkeys (Macaca mulatta). Diabetes 1999, 48, 1026-1034.